Navigation Links
Sun Pharma Announces Expiration of Subsequent Offering Period
Date:9/29/2010

MUMBAI, India, Sept. 29 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Sun) (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced the expiration of the subsequent offering period to the tender offer by Sun's subsidiary Alkaloida Chemical Company Exclusive Group Ltd (Alkaloida) for all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro). Sun has been informed by Computershare, the Depositary for the Offer, that as of 12:00 midnight New York City time on September 28, 2010, a total of 29,382 Ordinary Shares had been tendered pursuant to the tender offer representing approximately 0.07% of the outstanding Ordinary Shares.  During the pendency of the subsequent offering period, no additional shares have been tendered.  All tendered Ordinary Shares were accepted for payment.

About Sun PharmaEstablished in 1983, listed since 1994 and headquartered in India, Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company.  It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.  In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, orthopedics and ophthalmology.  The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at www.sunpharma.com.

ContactsUday Baldota

Mira DesaiTel

+91 22 6645 5645, Xtn 605Tel

+91 22 6645 5645, Xtn 606Tel Direct

+91 22 66455605Tel Direct

+91 22 66455606Mobile

+91 98670 10529Mobile

+91 98219 23797E mail

uday.baldota@sunpharma.comE mail

mira.desai@sunpharma.comBrunswick Group for Sun Pharma

MacKenzie PartnersErin Becker/Nicki Kahner

Robert Marese+1 212 333 3810

+1 212 929 5500Arad Communications for Sun Pharma

GreenhillIrit Radia

Ashish Contractor+972-54-6699311

+1 212 389 1537
'/>"/>

SOURCE Sun Pharmaceutical Industries Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 CENTRO DE ... article 157, paragraph 4 of Law 6,404/76 and Instruction ... hereby informs its shareholders and the market in general ... its subsidiary Centro de Diagnosticos por Imagem Ltda. (" ... 100% interest in RADIOLOGISTAS ASSOCIADOS LTDA. (" Partnership " ...
(Date:3/23/2017)... 23, 2017  The goal of the pilot ... and track prescription drugs as they are distributed in ... to requirements from US FDA to better protect consumers ... medicines. Blockchain startup Chronicled, which links ... and blockchain technology and recently raised $6.25M, and the ...
(Date:3/23/2017)... N.J. , March 23, 2017 /PRNewswire/ ... company, announced a major milestone today.  Following ... with the U.S. Food and Drug Administration ... clear clinical and regulatory path forward to ... CPI-613, in patients with acute myeloid leukemia ...
Breaking Medicine Technology:
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The MBI “Hall of Fame” recognizes the ... acts have had a significant impact on the careers of all others involved. ... Inc. was inducted into the MBI’s Hall of Fame. The induction took place during ...
(Date:3/23/2017)... OH (PRWEB) , ... March ... ... insurance and financial services firm serving the families and businesses of the ... community enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based ...
(Date:3/23/2017)... Atlanta, GA (PRWEB) , ... March 23, 2017 ... ... announced the release of SmartBen NOW, an innovative mobile app and centralized benefits ... gather and present critical information securely from multiple locations. For the first time, ...
(Date:3/23/2017)... Los Angeles, CA (PRWEB) , ... March 23, ... ... Series A funding investment in Los Angeles based healthcare technology company California Healthcom ... group’s portfolio into the US, and healthcare arena. With headquarters in California, CHG ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
Breaking Medicine News(10 mins):